000 01743 a2200493 4500
005 20250515002009.0
264 0 _c20051109
008 200511s 0 0 eng d
022 _a0300-9475
024 7 _a10.1111/j.1365-3083.2005.01644.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShimizu, I
245 0 0 _aEfficacy and limitations of cyclophosphamide-induced tolerance against alphaGal antigen.
_h[electronic resource]
260 _bScandinavian journal of immunology
_cSep 2005
300 _a271-80 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies
_ximmunology
650 0 4 _aAntigens
_ximmunology
650 0 4 _aB-Lymphocytes
_xdrug effects
650 0 4 _aChimerism
_xchemically induced
650 0 4 _aCyclophosphamide
_xpharmacology
650 0 4 _aFemale
650 0 4 _aGalactosyltransferases
_xdeficiency
650 0 4 _aGraft Rejection
_ximmunology
650 0 4 _aHeart Transplantation
_ximmunology
650 0 4 _aImmunosuppressive Agents
_xpharmacology
650 0 4 _aMice
650 0 4 _aMice, Mutant Strains
650 0 4 _aSkin Transplantation
_ximmunology
650 0 4 _aSpleen
_xcytology
650 0 4 _aTransplantation Tolerance
_ximmunology
650 0 4 _aTransplantation, Homologous
_ximmunology
650 0 4 _aTrisaccharides
_xgenetics
700 1 _aTomita, Y
700 1 _aIwai, T
700 1 _aKajiwara, T
700 1 _aOkano, S
700 1 _aSueishi, K
700 1 _aNomoto, K
700 1 _aYasui, H
773 0 _tScandinavian journal of immunology
_gvol. 62
_gno. 3
_gp. 271-80
856 4 0 _uhttps://doi.org/10.1111/j.1365-3083.2005.01644.x
_zAvailable from publisher's website
999 _c15810872
_d15810872